1.
Pituitary
; 26(3): 288-292, 2023 Jun.
Artículo
en Inglés
| MEDLINE
| ID: mdl-36971899
RESUMEN
Accurate localization of the site(s) of active disease is key to informing decision-making in the management of refractory pituitary adenomas when autonomous hormone secretion and/or continued tumor growth challenge conventional therapeutic approaches. In this context, the use of non-standard MR sequences, alternative post-acquisition image processing, or molecular (functional) imaging may provide valuable additional information to inform patient management.